![](/img/cover-not-exists.png)
A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma
Wagner-Johnston, Nina D., Goy, Andrè, Rodriguez, Maria A., Ehmann, W. Christopher, Hamlin, Paul A., Radford, John, Thieblemont, Catherine, Suh, Cheolwon, Sweetenham, John, Huang, Yifan, Sullivan, SharLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2015.1017821
Date:
March, 2015
File:
PDF, 663 KB
english, 2015